Physician
Ethos Pathology, INC
Ethos Pathology, INC was paid $198K by Medicaid between Jun 2019 and Aug 2024, across 64 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 22% of everything it billed.
33Billing provider infoETHOS PATHOLOGY, INC
DELRAY BEACH, FL 33484
DELRAY BEACH, FL 33484
33aNPI1902364664assigned 03/12/2019
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$198K
24GClaims138,593
24DCodes billed64
24AFirst – last monthJun 2019 – Aug 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#50 of 207
Median peer was paid$39K
This provider vs. median5.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 16,384 | $21K | |
| 2020 | 25,142 | $46K | |
| 2021 | 33,715 | $47K | |
| 2022 | 31,751 | $43K | |
| 2023 | 24,831 | $32K | |
| 2024incomplete | 6,770 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 22% | 3,574 | 3,117 | $43K |
| 80048 | Basic metabolic panel (calcium, ionized) | 16% | 15,639 | 6,518 | $31K |
| 80053 | Comprehensive metabolic panel | 14% | 9,891 | 5,228 | $28K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 7.5% | 1,636 | 1,508 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.3% | 17,850 | 8,782 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.8% | 454 | 423 | $8K |
| 83735 | 3.2% | 10,606 | 3,640 | $6K | |
| 87040 | 2.7% | 1,576 | 1,182 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 194 | 176 | $5K |
| 84484 | 2.3% | 3,106 | 2,182 | $4K | |
| 85610 | 1.6% | 4,543 | 3,051 | $3K | |
| 85027 | 1.5% | 7,773 | 2,577 | $3K |
52 more codes
| 82962 | 1.4% | 12,406 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 1,147 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.3% | 146 | $3K |
| 80076 | 1.3% | 3,114 | $3K | |
| 81001 | 1.2% | 4,975 | $2K | |
| 83605 | 1.1% | 1,504 | $2K | |
| 85730 | 1.1% | 4,503 | $2K | |
| 87070 | 1.0% | 1,559 | $2K | |
| 82803 | <1% | 1,574 | $2K | |
| 84703 | <1% | 3,267 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,684 | $2K |
| 86850 | <1% | 2,369 | $1K | |
| 84100 | <1% | 4,846 | $1K | |
| 87186 | <1% | 913 | $1K | |
| 83690 | <1% | 2,550 | $969.60 | |
| 82607 | <1% | 529 | $859.11 | |
| 87077 | <1% | 769 | $810.13 | |
| 80061 | Lipid panel | <1% | 676 | $686.82 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 165 | $580.79 |
| 86900 | <1% | 2,484 | $570.83 | |
| 82550 | <1% | 812 | $558.39 | |
| 80202 | <1% | 125 | $479.38 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 361 | $435.57 |
| 86901 | <1% | 2,486 | $393.36 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,640 | $380.59 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 654 | $317.26 |
| 83880 | <1% | 629 | $289.02 | |
| 80306 | <1% | 544 | $275.66 | |
| 86920 | <1% | 14 | $249.56 | |
| 85060 | <1% | 14 | $199.39 | |
| 87205 | <1% | 837 | $198.84 | |
| 86141 | <1% | 139 | $168.77 | |
| 85379 | <1% | 284 | $118.68 | |
| 82746 | <1% | 163 | $104.66 | |
| 82728 | <1% | 133 | $97.09 | |
| 87420 | <1% | 50 | $86.91 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 31 | $71.19 |
| 82140 | <1% | 27 | $52.64 | |
| 84702 | <1% | 28 | $51.14 | |
| 81025 | <1% | 31 | $46.30 | |
| 85652 | <1% | 105 | $37.19 | |
| 83540 | <1% | 80 | $32.47 | |
| 84439 | <1% | 84 | $31.20 | |
| 87081 | <1% | 33 | $17.80 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 47 | $10.42 |
| 80069 | <1% | 80 | $7.80 | |
| 84165 | <1% | 16 | $6.48 | |
| 82150 | <1% | 19 | $4.85 | |
| 85018 | <1% | 43 | $2.88 | |
| 82330 | <1% | 18 | $1.82 | |
| 83615 | <1% | 22 | $0.81 | |
| 84145 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRITO, DENESE (CEO/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ethos Pathology, INC | Lake Worth, FL | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.